![]() |
市场调查报告书
商品编码
1451173
2024-2032 年按测试类型、产品类型、技术类型、最终用户和地区分類的凝血分析仪市场报告Coagulation Analyzer Market Report by Testing Type, Product Type, Technology Type, End User, and Region 2024-2032 |
2023年,全球凝血分析仪市场规模达到58亿美元。展望未来, IMARC Group预计到2032年市场规模将达到108亿美元,2024-2032年复合年增长率(CAGR)为7%。
凝血,也称为血液学,是使血液形成凝块以治癒伤口的过程。医师主要使用凝血分析仪对血球进行定量和分类。进行不同类型的凝血试验,如PT、APTT、ACT等,以评估患者的凝血功能。大多数血液分析仪能够提供有关红血球 (RBC) 中血红蛋白、红血球资料、血小板计数和血细胞比容水平的资讯。然而,已经开发了一些新机器来测量两种特殊的细胞类型,其中包括有核红血球和未成熟的白血球。目前,由于患有血液疾病和生活方式疾病的人口持续增长,凝血分析仪的需求正在增加。
在过去的十年中,技术的快速进步和新的凝血分析仪测试的引入提高了止血实验室的品质和效率。一些现代复杂混凝器还具有高通量、灵活性和可靠性。除此之外,它们还提供了更高的准确度和精确度,以及易于使用的高级软体,并配有内建图形和校准曲线。此外,心臟病和血液疾病的盛行率显着上升,这导致全球范围内需要改进的凝血分析仪。除此之外,凝血分析仪的销售也受到全球越来越多的医院、诊断中心和研究机构的正面影响。
The global coagulation analyzer market size reached US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.
Coagulation, also known as hematology, is a process that enables the blood to create a clot to heal a wound. Physicians primarily use coagulation analyzers for quantifying and classifying blood cells. Different types of coagulation tests, such as PT, APTT, ACT, etc., are carried out for assessing blood clotting function in patients. Most of the hematology analyzers are capable of providing information about hemoglobin in red blood cells (RBCs), corpuscular data, platelet counts and hematocrit levels. However, some new machines have been developed to measure two specialized cell types, which include nucleated RBCs and immature white cells. At present, coagulation analyzers are experiencing a rise in their demand on account of consistent growth in the population suffering from blood disorders and lifestyle diseases.
Over the past decade, rapid advancements in technology and the introduction of new coagulation analyzer tests have led to an increase in the quality and efficiency of hemostasis laboratories. Some of the modern complex coagulators also possess high throughput, flexibility and reliability. Other than this, they provide improved accuracy and precision, and easy-to-use advanced software provided with in-built graphs and calibration curves. Moreover, there has been a significant rise in the prevalence of cardiac diseases and blood disorders, which has created the need for improved coagulation analyzers across the globe. Besides this, the sales of coagulation analyzers are positively being influenced by the increasing number of hospitals, diagnostic centers and research institutes established worldwide.
IMARC Group provides an analysis of the key trends in each sub-segment of the global coagulation analyzer market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on testing type, product type, technology type and end user.
Prothrombin Time Testing (PT)
Fibrinogen Testing
Activated Partial Thromboplastin Time Testing (APTT)
Activated Clotting Time Testing (ACT)
D-Dimer Testing
Platelet Function Testing
Anti-Factor Xa Testing
Others
Instruments/Analyzers
Automated Analyzers
Semi-Automated Analyzers
Manual Analyzers
Reagents
Consumables
Others
Optical Technology
Mechanical Technology
Electrochemical Technology
Others
Clinical Laboratories
Diagnostic Centers
Hospitals
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Roche Diagnostics (F. Hoffmann-La Roche Ltd.), Nihon Kohden, Sysmex Corporation, Siemens Healthineers Company, Thermo Fisher Scientific Inc., Helena Laboratories Corporation, DIAGNOSTICA STAGO, Instrumentation Laboratory Company, etc.